Approval · Notice of Compliance 23257 · 2020
VICTOZA: Notice of Compliance 23257
Issued February 26, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23257
- Date
- February 26, 2020
- Company
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Expansion of indication
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VICTOZA | Not yet assigned | — |
Medicinal ingredients
- LIRAGLUTIDE 6 MG per ML